Effect of Chlorhexidine Gel on Bacterial Count During Fixed Orthodontic Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02001311|
Recruitment Status : Unknown
Verified November 2013 by Dr. Samar Al-Bazi, King Abdulaziz University.
Recruitment status was: Not yet recruiting
First Posted : December 4, 2013
Last Update Posted : December 4, 2013
This study investigates the benefit of using chlorhexidine gel as an antimicrobial agent in orthodontic patient to reduce caries risk and the possible consequential effect of this use on the orthodontic brackets used for the treatment.
The investigators hypothesis is that chlorhexidine gel use can reduce caries risk in orthodontic patients with out causing damage to the bonded ceramic or metal orthodontic brackets.
|Condition or disease||Intervention/treatment||Phase|
|Orthodontic Appliance Complication Dental Caries||Drug: Chlorhexidine gluconate||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||20 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Effect of Chlorhexidine Gel on Bacterial Count and Orthodontic Brackets During Fixed Orthodontic Treatment; In-vivo & In-vitro Study|
|Study Start Date :||January 2014|
|Estimated Primary Completion Date :||April 2014|
|Estimated Study Completion Date :||June 2014|
Experimental: chlorhexidine gel
anti microbial agent that prevents the formation of plaque and reduces caries risk
Drug: Chlorhexidine gluconate
- mutants streptococcus count [ Time Frame: 48 hours ]measures the change in bacterial count before and after application of the gel
- friction [ Time Frame: 2 minutes ]measures static and dynamic friction in Newton
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02001311
|Contact: Mona A Abbassyemail@example.com|
|Contact: Ahmed S Bakryfirstname.lastname@example.org|
|Principal Investigator:||Samar M Al-Bazi||King Abdulaziz University|